Black PC - Search Results

1

Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer.

Vandekerkhove G, Todenhöfer T, Annala M, Struss WJ, Wong A, Beja K, Ritch E, Brahmbhatt S, Volik SV, Hennenlotter J, Nykter M, Chi KN, North S, Stenzl A, Collins CC, Eigl BJ, Black PC, Wyatt AW. Vandekerkhove G, et al. Among authors: black pc. Clin Cancer Res. 2017 Nov 1;23(21):6487-6497. doi: 10.1158/1078-0432.CCR-17-1140. Epub 2017 Jul 31. Clin Cancer Res. 2017. PMID: 28760909

2

Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells.

Black PC, Brown GA, Inamoto T, Shrader M, Arora A, Siefker-Radtke AO, Adam L, Theodorescu D, Wu X, Munsell MF, Bar-Eli M, McConkey DJ, Dinney CP. Black PC, et al. Clin Cancer Res. 2008 Mar 1;14(5):1478-86. doi: 10.1158/1078-0432.CCR-07-1593. Clin Cancer Res. 2008. PMID: 18316572

3

Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies.

Kollmannsberger C, Tyldesley S, Moore C, Chi KN, Murray N, Daneshmand S, Black P, Duncan G, Hayes-Lattin B, Nichols C. Kollmannsberger C, et al. Ann Oncol. 2011 Apr;22(4):808-814. doi: 10.1093/annonc/mdq466. Epub 2010 Oct 6. Ann Oncol. 2011. PMID: 20926549 Free article.

4

Morphological differences between circulating tumor cells from prostate cancer patients and cultured prostate cancer cells.

Park S, Ang RR, Duffy SP, Bazov J, Chi KN, Black PC, Ma H. Park S, et al. Among authors: black pc. PLoS One. 2014 Jan 8;9(1):e85264. doi: 10.1371/journal.pone.0085264. eCollection 2014. PLoS One. 2014. PMID: 24416373 Free PMC article.

5

Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.

Kollmannsberger C, Tandstad T, Bedard PL, Cohn-Cedermark G, Chung PW, Jewett MA, Powles T, Warde PR, Daneshmand S, Protheroe A, Tyldesley S, Black PC, Chi K, So AI, Moore MJ, Nichols CR. Kollmannsberger C, et al. Among authors: black pc. J Clin Oncol. 2015 Jan 1;33(1):51-7. doi: 10.1200/JCO.2014.56.2116. Epub 2014 Aug 18. J Clin Oncol. 2015. PMID: 25135991

6

Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Zargar H, Espiritu PN, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Vasdev N, Yu EY, Youssef D, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Garcia JA, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC. Zargar H, et al. Among authors: black pc. Eur Urol. 2015 Feb;67(2):241-9. doi: 10.1016/j.eururo.2014.09.007. Epub 2014 Sep 23. Eur Urol. 2015. PMID: 25257030 Free PMC article.

7

Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists.

Hsu T, Black PC, Chi KN, Canil CM, Eigl BJ, Kulkarni G, North S, Wood L, Zlotta AR, Lau A, Panzarella T, Sridhar SS. Hsu T, et al. Among authors: black pc. Can Urol Assoc J. 2014 Sep;8(9-10):309-16. doi: 10.5489/cuaj.2111. Can Urol Assoc J. 2014. PMID: 25408794 Free PMC article.

8

Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature.

Kluth LA, Black PC, Bochner BH, Catto J, Lerner SP, Stenzl A, Sylvester R, Vickers AJ, Xylinas E, Shariat SF. Kluth LA, et al. Among authors: black pc. Eur Urol. 2015 Aug;68(2):238-53. doi: 10.1016/j.eururo.2015.01.032. Epub 2015 Feb 21. Eur Urol. 2015. PMID: 25709027 Review.

9

Size and deformability based separation of circulating tumor cells from castrate resistant prostate cancer patients using resettable cell traps.

Qin X, Park S, Duffy SP, Matthews K, Ang RR, Todenhöfer T, Abdi H, Azad A, Bazov J, Chi KN, Black PC, Ma H. Qin X, et al. Among authors: black pc. Lab Chip. 2015 May 21;15(10):2278-86. doi: 10.1039/c5lc00226e. Lab Chip. 2015. PMID: 25876237

10

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.

Jäger W, Xue H, Hayashi T, Janssen C, Awrey S, Wyatt AW, Anderson S, Moskalev I, Haegert A, Alshalalfa M, Erho N, Davicioni E, Fazli L, Li E, Collins C, Wang Y, Black PC. Jäger W, et al. Among authors: black pc. Oncotarget. 2015 Aug 28;6(25):21522-32. doi: 10.18632/oncotarget.3974. Oncotarget. 2015. PMID: 26041878 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

372 results

Search Page